Standardize Processes for Med Dosing in Obesity

June 2021

Clear guidance can be hard to come by for med dosing in patients with obesity...a body mass index (BMI) of 30 or higher.

Less than 15% of package inserts for acute care meds give adequate dosing info for these patients. And even fewer labels provide guidance for severe obesity...a BMI of 40 or more.

Plus there isn’t a reliable rule of thumb based on any single drug property...such as lipophilicity or volume of distribution.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

COVID-19 Answer Questions About COVID-19 Vaccines for Kids 12 and Up
Psychiatry Be Alert for PTSD Linked to the COVID-19 Pandemic
Substance Use Disorder Improve Access to Buprenorphine for Opioid Use Disorder
COVID-19 Help Build Trust in COVID-19 Vaccines
COVID-19 Clarify the Role of Home Tests for COVID-19
Warnings Put Arrhythmia Warnings for Lamotrigine in Context
Communication Be Ready to Help People Who Are Deaf or Hard of Hearing
Ear, Nose & Throat Give Advice on How to Treat and Prevent Nosebleeds
Rosacea Sort Through Topical Meds for Rosacea
Liver Disease Don’t Jump to Albumin for Decompensated Liver Disease
Radiology Optimize Safety With IV Contrast Agents
Dosing Standardize Processes for Med Dosing in Obesity
Cystic Fibrosis Look for Cystic Fibrosis Patients Taking Bronchitol

Standardize Processes for Med Dosing in Obesity

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents